Vita Life Sciences Faces Volatile Stock & Strategic Challenges in Pharma
Vita Life Sciences’ dual focus on vitamins, supplements and medical diagnostic tech drives its volatile ASX stock—investors weigh high PE, growth prospects and industry challenges.
2 minutes to read